The Pattern That Both Parties Pretend Not to See
In 2019, Scott Gottlieb resigned as Commissioner of the Food and Drug Administration after a tenure that included significant decisions affecting pharmaceutical pricing, drug approval timelines, and opioid regulation. Within months, he had joined the board of Pfizer — one of the world's largest pharmaceutical companies and a firm whose products and business practices had been subject to FDA oversight throughout his tenure. Gottlieb is a capable and credentialed man, and his appointment to Pfizer's board was entirely legal under existing ethics rules. That is precisely the problem.
The revolving door between federal regulatory agencies and the industries they oversee is not a rare exception or an occasional lapse in an otherwise sound system. It is a structural feature of the modern administrative state — one that has been documented by watchdog groups, academic researchers, and government inspectors general across administrations of both parties. It operates so consistently, at such scale, and with such predictable consequences for regulatory behavior that describing it as anything other than institutionalized corruption requires a level of willful naivety that serious observers should no longer be willing to perform.
How the System Works — and Who Benefits
The revolving door operates in two directions. The more commonly discussed direction runs from government to industry: a regulator spends years at an agency, develops expertise in a specific regulatory domain, builds relationships with industry stakeholders, and then monetizes that expertise and those relationships by taking a senior position at a regulated firm or a lobbying shop that represents regulated firms.
The less-discussed direction runs from industry to government: a corporate lawyer or pharmaceutical executive takes a senior position at the agency that regulates her former employer, participates in rule-making that shapes her former industry's competitive landscape, and then — after satisfying whatever nominal cooling-off period applies — returns to the private sector with enhanced credentials and an even more valuable network.
Both directions create the same fundamental problem: regulatory capture. When the people writing the rules know that their next employer may be the company most affected by those rules, the incentive structure is corrupted at its foundation. Regulations that would disadvantage powerful incumbents get softened. Approval processes that would benefit large, well-connected firms get streamlined. Enforcement actions against companies where former colleagues now work get deprioritized. None of this requires explicit corruption or quid pro quo arrangements — it operates through the subtler mechanics of anticipated reciprocity, professional relationships, and the simple human tendency to avoid burning bridges with people who may sign your next paycheck.
The Evidence Is Not Anecdotal
The scale of the revolving door has been documented extensively. A 2016 study by the Project On Government Oversight examined 33 major federal agencies and found that, over a five-year period, more than 1,400 former federal employees had registered as lobbyists for clients with business before their former agencies. The financial sector provides particularly stark examples: a 2013 analysis by the nonprofit organization Better Markets found that the Securities and Exchange Commission had employed 219 former private-sector financial industry workers, while simultaneously sending hundreds of former SEC employees into private-sector positions representing financial firms before the agency.
The FDA's relationship with the pharmaceutical industry is similarly well-documented. A 2018 study published in the British Medical Journal examined the post-government employment of 55 senior FDA officials who had left the agency between 2006 and 2019. The majority went to work for pharmaceutical companies or firms representing pharmaceutical clients. The researchers found evidence of a correlation between the permissiveness of officials' regulatory decisions during their government tenure and the likelihood of their subsequent industry employment — though correlation does not establish causation, and the study's authors were appropriately cautious about their conclusions.
At the EPA, the pattern repeats: senior officials who oversee environmental regulations affecting the energy, chemical, and agricultural sectors routinely depart for positions at the trade associations and law firms that represent those sectors. The Commodity Futures Trading Commission, the Federal Communications Commission, the Department of Defense's acquisition offices — the list of agencies where the revolving door operates at scale is essentially a list of every major federal regulatory and procurement body.
The Ethics Rules Are Theater
Federal law does impose post-employment restrictions on former government officials. The primary statute — 18 U.S.C. § 207 — prohibits former senior officials from lobbying their former agencies on matters in which they were personally and substantially involved, for a period of one to two years depending on the seniority of the position. Cabinet secretaries and other very senior officials face a two-year ban on contacting their former agencies on any matter, and a one-year ban on contacting any senior executive branch official.
These restrictions sound meaningful. They are not. The two-year cooling-off period for the most senior officials is barely sufficient to dim the institutional memory of former colleagues, much less to eliminate the value of relationships built over years of regulatory work. More importantly, the restrictions apply to formal lobbying contacts — they do not prevent former officials from advising private clients on regulatory strategy, reviewing regulatory submissions, coaching junior lobbyists who do the direct agency contact, or joining corporate boards where their expertise and relationships provide value without triggering the technical definition of lobbying.
The Office of Government Ethics, which is nominally responsible for overseeing these restrictions, has a budget of approximately $20 million per year and a staff of fewer than 80 people to oversee an executive branch workforce of roughly 2.1 million. Enforcement is episodic, penalties for violations are modest, and the culture of the federal workforce treats the revolving door not as a scandal to be avoided but as a career milestone to be achieved.
The Strongest Defense — and Its Limits
The most intellectually serious argument for the current system is that it is necessary to attract talented people to government service. If former regulators could never work in their areas of expertise, the argument goes, the most capable professionals would avoid government positions, leaving agencies staffed by people who lack the practical knowledge to regulate complex industries effectively. There is genuine truth in this. The FDA requires people who understand drug development. The SEC requires people who understand financial markets. Overly rigid post-employment restrictions could impoverish the regulatory talent pool.
But this argument, compelling as it is at the margins, does not justify the current system's near-total permissiveness. The choice is not between a two-year cooling-off period and a lifetime ban on private-sector employment. A five-year restriction on direct employment with regulated firms — combined with a genuine prohibition on informal advisory work during that period, real enforcement authority, and meaningful penalties — would substantially reduce the capture problem without eliminating the government's ability to recruit industry expertise. Congress has simply never had sufficient political will to impose such restrictions, because the members of Congress who would vote on them are subject to their own version of the same revolving door.
What Genuine Reform Requires
The conservative case for revolving-door reform is distinct from the progressive one, and it is worth stating clearly. This is not primarily an argument about inequality or corporate power in the abstract. It is an argument about the legitimacy of the administrative state and the integrity of the rule of law. When regulations are written by officials who have financial incentives to favor the regulated industry, those regulations do not represent neutral application of statutory mandates — they represent a corruption of the legislative intent that created the agency in the first place.
Conservatives who favor limited government and free markets should be especially alarmed by regulatory capture, because captured regulators do not produce deregulation — they produce regulation that entrenches incumbents, raises barriers to entry for competitors, and uses the coercive power of the state to benefit the connected at the expense of the competitive. That is not capitalism. It is cronyism wearing a regulatory badge.
Meaningful reform requires extending cooling-off periods to at least five years for senior officials, closing the informal advisory loophole, significantly expanding the OGE's enforcement budget and authority, and creating criminal penalties — not merely civil fines — for material violations. It also requires a cultural shift: treating the revolving door not as a perk of public service but as a betrayal of it.
A regulatory state that writes rules for its next employer rather than the public it was chartered to protect is not a check on corporate power — it is corporate power wearing a government seal.
